Navigation Links
Gel pares inflammatory activity throughout body

Treating periodontal infections with an antibiotic gel reduced the presence of two chemical markers of inflammation throughout the body,// pointing to further evidence of the connection between oral health and overall health, investigators from the University at Buffalo School of Dental Medicine have found.

The investigators divided a sample of 100 adults with chronic periodontal disease into four groups, two of which had an antibiotic-infused gel applied to their periodontal pockets while the other two received standard treatment without the gel. Treatment was administered at the beginning of the study and again three months later.

Following treatment, the groups that received the gel showed not only lower levels of oral bacteria but also a decrease in the amounts of C-reactive protein and fibrinogen in the blood stream, according to the study results. These two markers of inflammatory activity are associated with the development of atherosclerosis and other chronic diseases. The reduction in C-reactive protein remained for six months.

"Several studies conducted here and elsewhere have found oral bacteria from gum infections in arterial plaque. Now we have shown that therapy for periodontal disease lessens the inflammatory burden throughout the body."

The University at Buffalo is one of five research centers participating in a three-year study examining the relationship between periodontal infection and cardiovascular disease sponsored by the National Institute of Dental and Craniofacial Research.


'"/>




Page: 1

Related medicine news :

1. Mizoram Prepares To Combat Bird Flu
2. Philippines Government prepares to counter bird flu
3. UK Prepares Itself For Flu Pandemic
4. New Zealand Prepares Itself For Pandemic
5. India Prepares Itself For H5N1
6. Bulgaria Prepares Itself For Combating Bird Flu Outbreak
7. San Diego Zoo Prepares Itself Against Bird Flu
8. Britain Prepares For Mass Burials To Encounter Future Bird Flu Deaths
9. Fresh Cases of Bird-Flu Prepares the Ground for More Chicken Martyrs
10. Internet Dating Spares None
11. FAO Prepares Seychelles to Tackle Bird Flu Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: